Recent News

By Category: Biotechnology

Naval Research Lab Develops Nanofibers for Chemical and Biological Decontamination

Chemical and biological threats pose a significant concern not only to the modern warfighter but an ever-increasing number of individuals and groups. This threat is compounded by the persistence of these agents and the possibilities of causing increased personnel exposure … Continue reading →

Synchrotron yields ‘safer’ vaccine – BBC News

BBC NewsSynchrotron yields 'safer' vaccineBBC News"This technology has great potential in terms of cost and biosafety. "Any design strategy that minimises the chances of accidental virus release would not only make the world a safer place but would lower the bio-containment barriers to production …and more »

Synchrotron yields ‘safer’ vaccine – BBC News

BBC NewsSynchrotron yields 'safer' vaccineBBC News"This technology has great potential in terms of cost and biosafety. "Any design strategy that minimises the chances of accidental virus release would not only make the world a safer place but would lower the bio-containment barriers to production …and more »

Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013

(Marketwire) Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiological and chemical threats and for use in oncology, provided an update to investors on the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA). The bill was signed into law today  Read More »

Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013

MISSION VIEJO, CA–(Marketwire – Mar 14, 2013) – Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)